Search
for
Sort by
Research 31–60 of 78
- Post‐finasteride syndrome: real or myth?
- Post-finasteride syndrome: An emerging clinical problem
- Role of Dutasteride in the Treatment of Androgenetic Alopecia
- Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs
- Finasteride and androgenic alopecia; from therapeutic options to medical implications
- FINASTERIDE IN MODERN MEDICINE: THERAPEUTIC APPLICATIONS AND SYSTEMIC HEALTH IMPLICATIONS
- ‘Post-finasteride syndrome’: what to tell our female patients?
- Current Landscape and Emerging Therapies in Hair Loss Treatment for Androgenetic Alopecia
- Post-finasteride syndrome – does it really exist?
- Finasteride-Induced Neuropsychiatric Reactions
- Androgenetic alopecia; drug safety and therapeutic strategies
- Open-label placebos reduce hair cortisol concentrations and psychological distress - a randomized controlled trial
- 5-Alpha-Reductase Inhibitors in the Treatment of Male Androgenetic Alopecia: Clinical Experience
- How to Deal with the Issues of Fertility, Malignancies, and the Postfinasteride Syndrome while Prescribing Finasteride for Male Pattern Hair Loss
- Post-finasteride syndrome
- Abstracts from the current global literature: Finasteride and sexual dysfunction
- Treatment of Crohn's Disease and Concomitant Alopecia Areata With Tofacitinib
- Sexual Dysfunctions Related to Drugs Used in the Management of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Narrative Review on α-Blockers and 5-Alpha Reductase Inhibitors
- The post-finasteride syndrome: possible etiological mechanisms and symptoms
- Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: A randomized controlled open-label, evaluator-blinded study
- Caffeine as an Active Ingredient in Cosmetic Preparations Against Hair Loss: A Systematic Review of Available Clinical Evidence
- Guidelines on the use of finasteride in androgenetic alopecia
- Investigation of the Plausibility of 5-Alpha-Reductase Inhibitor Syndrome
- TREATMENT PEARLS FROM EUROPE
- ORAL AND TOPICAL FINASTERIDE IN THE TREATMENT OF MALE ANDROGENETIC ALOPECIA – NARRATIVE REVIEW
- What do users in a polycystic ovary syndrome (PCOS) forum think about the treatments they tried: Analysing treatment sentiment using machine learning
- Abstracts from the 17th Congress of the European Society for Dermatology and Psychiatry
- Persistent Erectile Dysfunction after Discontinuation of 5-Alpha Reductase Inhibitor Therapy in Rats Depending on the Duration of Treatment
- Persistent sexual dysfunction and depression in finasteride users for male pattern hair loss: a serious concern or red herring?
- Disproportional signal of sexual dysfunction reports associated with finasteride use in young men with androgenetic alopecia: A pharmacovigilance analysis of VigiBase